US

Urmila Sharma

Director Director DIN 07416594
DIN 07416594 First appointment Mar 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2016
Shareholding value Locked Premium profile

About Urmila Sharma

Data last updated:

Urmila Sharma has 10 years in corporate governance. Formerly with 1 company, such as Protea Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07416594
Primary Designation Director
First Appointment 17 Mar 2016
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Protea Pharma Private Limited U24230MP2016PTC035562
Director17 Mar 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Protea Pharma Private Limited
Premium access

Shareholding and investment profile for Urmila Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmila Sharma

Urmila Sharma has 10 years in corporate governance. Formerly with 1 company, such as Protea Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Urmila Sharma is associated with 0 companies as a director.

Urmila Sharma has expertise in General Business.

Urmila Sharma has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available